Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

465
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
465
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

379
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
379
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

332
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
332
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

657
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
657

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of the optimal obesity-adjusted dosing weight for enoxaparin.

British journal of clinical pharmacology·2024
Same author

Comparing the diagnostic adequacy of 25-Gauge fork-tip <i>versus</i> franseen <i>versus</i> reverse-bevel-type needles in EUS-guided tissue acquisition: A prospective randomized study with a retrospective control.

Endoscopic ultrasound·2024
Same author

Challenges Associated with the Effective Implementation of New Laboratory Tests-The International Experience.

Clinical chemistry·2024
Same author

Malglycemia in the critical care setting. Part III: Temporal patterns, relative potencies, and hospital mortality.

Journal of critical care·2024
Same author

Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility.

BMJ open·2023
Same author

A National Survey of Patient Data Capture, Management, Reporting Practice in Australian Cardiac Rehabilitation Programs.

Heart, lung & circulation·2023

Related Experiment Video

Updated: Mar 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

How to manage warfarin therapy.

Philip A Tideman1, Rosy Tirimacco1, Andrew St John2

  • 1Australian Point of Care Practitioners Network ; Integrated Cardiovascular Clinical Network, Country Health South Australia, Adelaide.

Australian Prescriber
|December 10, 2015
PubMed
Summary

Warfarin is recommended for atrial fibrillation patients at risk of stroke. Patient education and self-monitoring with point-of-care testing improve outcomes for warfarin users.

Keywords:
INRanticoagulantspoint-of-care serviceswarfarin

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

Related Experiment Videos

Last Updated: Mar 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Long-term warfarin therapy is crucial for patients with atrial fibrillation (AF) at risk of stroke.
  • It is also indicated for recurrent venous thrombosis and prosthetic heart valves.
  • Effective warfarin management requires comprehensive patient education and regular monitoring.

Purpose of the Study:

  • To outline the key components of successful warfarin management.
  • To emphasize the importance of patient education and monitoring strategies.

Main Methods:

  • Review of current guidelines and evidence regarding warfarin therapy.
  • Discussion of patient education topics: bleeding risks, diet, drug interactions, and missed doses.
  • Highlighting the role of scoring systems (e.g., CHADS2) in treatment decisions.
  • Mentioning age-adjusted protocols for initiating warfarin and the necessity of regular monitoring.
  • Examining the benefits of self-monitoring using point-of-care testing.

Main Results:

  • Patient education is pivotal for safe and effective warfarin use.
  • Age-adjusted protocols facilitate rapid achievement of stable anticoagulation.
  • Regular monitoring of anticoagulant effect is essential.
  • Self-monitoring with point-of-care testing is associated with improved patient outcomes.

Conclusions:

  • Optimizing warfarin therapy involves thorough patient education, appropriate initiation protocols, and consistent monitoring.
  • Point-of-care self-monitoring may lead to better outcomes in patients on long-term warfarin treatment.